[EN] CAFFEINATED COMPOUNDS AND COMPOSITIONS FOR TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES<br/>[FR] COMPOSÉS CAFÉINÉS ET COMPOSITIONS POUR LE TRAITEMENT DE MALADIES AMYLOÏDES ET SYNUCLÉINOPATHIES
申请人:PROTEOTECH INC
公开号:WO2013062762A1
公开(公告)日:2013-05-02
Compounds and their pharmaceutically acceptable salts for treatment of β-amyloid diseases, such as observed in Alzheimer's disease and synucleinopathies, such as Parkinson's disease.
CAFFEINATED COMPOUNDS AND COMPOSITIONS FOR TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES
申请人:Proteo Tech Inc
公开号:US20140194447A1
公开(公告)日:2014-07-10
Compounds and their pharmaceutically acceptable salts for treatment of β-amyloid diseases, such as observed in Alzheimer's disease and synucleinopathies, such as Parkinson's disease.
[EN] STILBENE DERIVATIVES, A METHOD FOR PREPARATION THEREOF, AND ITS USE<br/>[FR] DERIVES DE STILBENE, PROCEDE DE PREPARATION CORRESPONDANT ET UTILISATION CORRESPONDANTE
申请人:PACIFIC CORP
公开号:WO2003010121A1
公开(公告)日:2003-02-06
The present invention relates to stilbene derivatives ; a method of preparation therefor ; and a medicinal composition for treating hyperpigmentation and a cosmetic composition for whitening skin containing the stilbene derivatives as an active ingredient.
[EN] ISOCHROMENONES USEFUL IN THE TREATMENT OF INFLAMMATION<br/>[FR] ISOCHROMÉNONES UTILISABLES DANS LE TRAITEMENT DE L'INFLAMMATION
申请人:BIOLIPOX AB
公开号:WO2010076564A2
公开(公告)日:2010-07-08
This invention is directed to compounds of formula (I): wherein R1, R2, R3, Rx, Ry, m and n have meanings given in the description, or pharmaceutically acceptable salts, solvates or prodrugs thereof, which are useful as PDE4, PDE7 or PDE4 and PDE7 inhibitors, and therefore useful e.g. in the treatment and/or prevention of diseases and conditions associated with inflammation.